[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Controversies in Internal Medicine
February 26, 2007

The Case for Infectious Endocarditis ProphylaxisTime to Move Forward

Author Affiliations

Author Affiliations:Center for Outcomes Research and Evaluation, The Queen's Medical Center, and Division of Cardiology, Department of Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, Hawaii.

 

B. NATTINGERANNMD, MPH

Arch Intern Med. 2007;167(4):327-330. doi:10.1001/archinte.167.4.327

The concept of using antibacterial agents to prevent infectious endocarditis (IE) was proposed more than 60 years ago1and was first endorsed by the American Heart Association (AHA) in its recommendations for IE prophylaxis published in 1955.2Since that time, IE prophylaxis has become a widely accepted preventive measure, broadly endorsed by a number of international professional societies, representing cardiologists, gastroenterologists, infectious diseases specialists, dentists, and pediatricians.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×